Predictive Oncology Pre-Tax Profit Margin 2010-2024 | POAI
Predictive Oncology Pre-Tax Profit Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
2024-12-31 | $0.00B | $-0.01B | -1000.00% |
2024-09-30 | $0.00B | $-0.01B | 0.00% |
2024-06-30 | $0.00B | $-0.01B | -1200.00% |
2024-03-31 | $0.00B | $-0.01B | -1300.00% |
2023-12-31 | $0.00B | $-0.01B | -1200.00% |
2023-09-30 | $0.00B | $-0.02B | -1800.00% |
2023-06-30 | $0.00B | $-0.02B | 0.00% |
2023-03-31 | $0.00B | $-0.03B | 0.00% |
2022-12-31 | $0.00B | $-0.03B | 0.00% |
2022-09-30 | $0.00B | $-0.03B | 0.00% |
2022-06-30 | $0.00B | $-0.03B | 0.00% |
2022-03-31 | $0.00B | $-0.02B | 0.00% |
2021-12-31 | $0.00B | $-0.02B | 0.00% |
2021-09-30 | $0.00B | $-0.02B | 0.00% |
2021-06-30 | $0.00B | $-0.02B | 0.00% |
2021-03-31 | $0.00B | $-0.03B | 0.00% |
2020-12-31 | $0.00B | $-0.03B | 0.00% |
2020-09-30 | $0.00B | $-0.03B | 0.00% |
2020-06-30 | $0.00B | $-0.03B | -2700.00% |
2020-03-31 | $0.00B | $-0.02B | -2200.00% |
2019-12-31 | $0.00B | $-0.02B | -2000.00% |
2019-09-30 | $0.00B | $-0.01B | -900.00% |
2019-06-30 | $0.00B | $-0.01B | 0.00% |
2019-03-31 | $0.00B | $-0.01B | 0.00% |
2018-12-31 | $0.00B | $-0.01B | 0.00% |
2018-09-30 | $0.00B | $-0.01B | 0.00% |
2018-06-30 | $0.00B | $-0.01B | 0.00% |
2018-03-31 | $0.00B | $-0.01B | 0.00% |
2017-12-31 | $0.00B | $-0.01B | 0.00% |
2017-09-30 | $0.00B | $-0.01B | 0.00% |
2017-06-30 | $0.00B | $-0.01B | 0.00% |
2017-03-31 | $0.00B | $-0.01B | 0.00% |
2016-12-31 | $0.00B | $-0.01B | 0.00% |
2016-09-30 | $0.00B | $-0.01B | 0.00% |
2016-06-30 | $0.00B | $-0.01B | 0.00% |
2016-03-31 | $0.00B | $-0.01B | 0.00% |
2015-12-31 | $0.00B | $0.00B | 0.00% |
2015-09-30 | $0.00B | $0.00B | 0.00% |
2015-06-30 | $0.00B | $0.00B | 0.00% |
2015-03-31 | $0.00B | $-0.01B | 0.00% |
2014-12-31 | $0.00B | $-0.01B | 0.00% |
2014-09-30 | $0.00B | $-0.01B | 0.00% |
2014-06-30 | $0.00B | $-0.01B | 0.00% |
2014-03-31 | $0.00B | $-0.01B | 0.00% |
2013-12-31 | $0.00B | $-0.01B | 0.00% |
2013-09-30 | $0.00B | $-0.01B | 0.00% |
2013-06-30 | $0.00B | $-0.01B | 0.00% |
2013-03-31 | $0.00B | $-0.01B | 0.00% |
2012-12-31 | $0.00B | $-0.01B | 0.00% |
2012-09-30 | $0.00B | $-0.01B | 0.00% |
2012-06-30 | $0.00B | $-0.01B | 0.00% |
2012-03-31 | $0.00B | $-0.01B | 0.00% |
2010-03-31 | $0.00B | $0.00B | 0.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.010B | $0.002B |
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $37.687B | 52.05 |
Tempus AI (TEM) | United States | $9.349B | 0.00 |
Hims & Hers Health (HIMS) | United States | $7.785B | 125.14 |
Inspire Medical Systems (INSP) | United States | $4.759B | 92.44 |
IRhythm Technologies (IRTC) | United States | $3.404B | 0.00 |
Privia Health (PRVA) | United States | $2.840B | 212.82 |
Enovis (ENOV) | United States | $1.994B | 12.34 |
Schrodinger (SDGR) | United States | $1.883B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.763B | 0.00 |
Omnicell (OMCL) | United States | $1.471B | 31.72 |
Phreesia (PHR) | United States | $1.461B | 0.00 |
Azenta (AZTA) | United States | $1.216B | 56.62 |
10x Genomics (TXG) | United States | $1.025B | 0.00 |
Butterfly Network (BFLY) | United States | $0.583B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.560B | 0.00 |
Talkspace (TALK) | United States | $0.532B | 316.00 |
Veradigm (MDRX) | United States | $0.457B | 0.00 |
Standard BioTools (LAB) | United States | $0.440B | 0.00 |
TruBridge (TBRG) | United States | $0.389B | 0.00 |
Claritev (CTEV) | United States | $0.373B | 0.00 |
Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
Pulmonx (LUNG) | United States | $0.212B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.211B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.204B | 0.00 |
American Well (AMWL) | United States | $0.114B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.085B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.082B | 0.00 |
CareCloud (CCLD) | United States | $0.077B | 3.31 |
111 (YI) | China | $0.072B | 0.00 |
P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
HeartBeam (BEAT) | United States | $0.061B | 0.00 |
Outset Medical (OM) | United States | $0.041B | 0.00 |
Zepp Health (ZEPP) | China | $0.040B | 0.00 |
Zhongchao (ZCMD) | China | $0.028B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
Movano (MOVE) | United States | $0.006B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |